Results 31 to 40 of about 20,963 (287)

Unpacking and understanding the impact of proprotein convertase subtilisin/kexin type 9 inhibitors on apolipoprotein B metabolism [PDF]

, 2017
No abstract ...
Packard, Chris J.
core   +1 more source

Low Remnant Cholesterol and In‐Hospital Bleeding Risk After Ischemic Stroke or Transient Ischemic Attack

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Bleeding risk brought by intensive lipid‐lowering therapy and low low‐density lipoprotein cholesterol is concerning, while evidence regarding the relationship between remnant cholesterol and bleeding is frightening.
Zhiyuan Wu, Haiping Zhang, Yi Xu, Xia Li, Xingang Li, Lois Balmer, Xiuhua Guo, Qi Zhang, Xiang Han, Lixin Tao   +9 more
doaj   +1 more source

Remnant cholesterol, stronger than triglycerides, is associated with incident non-alcoholic fatty liver disease

Frontiers in Endocrinology, 2023
IntroductionNon-alcoholic fatty liver disease (NAFLD) is characterized by excess accumulation of triglycerides within the liver. However, whether the circulating levels of triglycerides and cholesterol transported in triglyceride-rich lipoproteins ...
Yiping Cheng, Yiping Cheng, Qiang Zhang, Haizhen Li, Guangshuai Zhou, Ping Shi, Ping Shi, Xu Zhang, Xu Zhang, Liying Guan, Fang Yan, Chao Xu, Chao Xu   +12 more
doaj   +1 more source

Lipoprotein profiles of fat distribution and its association with insulin sensitivity

Frontiers in Endocrinology, 2022
BackgroundFat deposition is associated with adverse outcomes. Waist-to-hip (WHR) ratio is a simple feasible index to assess fat distribution. Lipoprotein particle composition in relation to WHR and to what extent their association is mediated by insulin ...
Dongmei Wei, Vannina González Marrachelli, Vannina González Marrachelli, Jesus D. Melgarejo, Chia-Te Liao, Stefan Janssens, Peter Verhamme, Thomas Vanassche, Lucas Van Aelst, Daniel Monleon, Daniel Monleon, Josep Redón, Zhen-Yu Zhang   +12 more
doaj   +1 more source

Role of Esrrg in the Fibrate-Mediated Regulation of Lipid Metabolism Genes in Human ApoA-I Transgenic Mice [PDF]

, 2009
We have used a new ApoA-I transgenic mouse model to identify by global gene expression profiling, candidate genes that affect lipid and lipoprotein metabolism in response to fenofibrate treatment.
A Chroni, A Duka, A Patsialou, A Rigotti, A Walsh, AP Feinberg, B Staels, B Staels, B Staels, B Staels, B Staels, B Staels, BN Finck, CW Miller, D Arsenijevic, D Lan, D Sanoudou, D Sanoudou, D Sanoudou, EM Rubin, ES Cathcart, F Yadetie, G Fredrikson, G Martin, H Duez, H Samyn, HB Rubins, HY Kan, J Karbowska, J Lin, J St Pierre, JC Fruchart, JD Brunzell, JJ Lehman, JK Reddy, JL Goldstein, JM Huss, JM Huss, JP Desager, K C Hayes, K Drosatos, K Motojima, K Schoonjans, K Schoonjans, KE Kypreos, KE Kypreos, KS Frederiksen, L Berthou, LA Pennacchio, LJ Kelly, M Bouly, MB Eisen, MC Hunt, MJ Holness, N Hennuyer, N Vu-Dac, N Vu-Dac, N Vu-Dac, N Vu-Dac, NF Cariello, P Puigserver, Q Guo, R Sladek, RB Vega, RL Jacobs, SA Greenberg, SN Schreiber, V Beisvag, V Giguere, V I Zannis, V Litvak, VG Tusher, VI Zannis, VI Zannis, VI Zannis, WC Roberts, X Prieur, Y Kamei, Y Nagai, Z Wu   +79 more
core   +3 more sources

Fasting and postprandial remnant-like particle cholesterol concentrations in obese participants are associated with plasma triglycerides, insulin resistance, and body fat distribution [PDF]

, 2008
Elevated plasma concentrations of remnant-like particle cholesterol (RLP-C) are atherogenic. However, factors that determine RLP-C are not fully understood.
Arner, P. (P.), Astrup, A. (Arne), Blaak, E.E. (Ellen E.), Dallinga-Thie, G.M. (Geesje M.), Hul, G.B. (Gabby B.), Martinez, J.A. (José Alfredo), Oppert, J.M. (Jean M.), Saris, W.H.M. (Wim H. M.), Sørensen, T.I.A (Thorkild I. A.), Van-Hees, A.M.J. (Anneke M.J.)   +9 more
core   +1 more source

Intraindividual Discordance Between Remnant Cholesterol and Low‐Density Lipoprotein Cholesterol Associated With Incident Stroke: Results From 2 National Cohorts

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background The atherogenic effect of remnant cholesterol is being increasingly acknowledged. This study aimed to explore the association of discordance between remnant cholesterol and low‐density lipoprotein cholesterol with stroke onset using 2 Chinese ...
Cancan Cui, Pingan Li, Yitian Qi, Jiayin Song, Tianjiao Han, Xinyun Shang, Lois Balmer, Chen Sheng, Yining Zha, Zhonghang Xu, Xu Wang, Zhiyuan Wu   +11 more
doaj   +1 more source

Impact of Remnant Cholesterol on the Risk for End-Stage Renal Disease in Type 2 Diabetes Mellitus: A Nationwide Population-Based Cohort Study [PDF]

Diabetes & Metabolism Journal
Background Remnant cholesterol (remnant-C) has been linked to the risk of various vascular diseases, but the association between remnant-C and end-stage renal disease (ESRD) in patients with type 2 diabetes mellitus (T2DM) remains unclear.
Eun Roh, Ji Hye Heo, Han Na Jung, Kyung-Do Han, Jun Goo Kang, Seong Jin Lee, Sung-Hee Ihm   +6 more
doaj   +1 more source

Remnant lipoprotein cholesterol is associated with incident new onset diabetes after transplantation (NODAT) in renal transplant recipients: results of the TransplantLines Biobank and cohort Studies

Cardiovascular Diabetology, 2022
Background New onset diabetes after transplantation (NODAT) is a frequent and serious complication of renal transplantation resulting in worse graft and patient outcomes.
Tamas Szili-Torok, Sara Sokooti, Maryse C. J. Osté, Antonio W. Gomes-Neto, Robin P. F. Dullaart, Stephan J. L. Bakker, Uwe J. F. Tietge   +6 more
doaj   +1 more source

Remnant cholesterol in obesity phenotypes: results from NHANES. [PDF]

Lipids Health Dis
The association between remnant cholesterol (RC) with obesity phenotypes remains unclear.This study designed to evaluate the association between RC and obesity phenotypes using data from the National Health and Nutrition Examination Survey (NHANES).
Yu T, Liu S, Fang L, Du T, Liu Z.
europepmc   +4 more sources